XVARY Composite Score
72
/ 100
Average
Combines growth, value, risk, and momentum factors into a single institutional-grade score.
Start here if you're new
What it is
Primerica sells term life insurance and investment products through a huge contractor sales force in the U.S. and Canada.
How it gets paid
Last year Primerica made $3.3B in revenue. Term life insurance was the main engine at $1.35B, or 41% of sales.
Why it's growing
Revenue grew 6.6% last year. EPS rising to $6.35 in the Q3 snapshot matters most because it shows operating leverage in a business that only grew the top line by.
What just happened
Primerica's latest quarter was strong, with EPS hitting $6.13 versus a $5.64 estimate.
At a Glance
A balance sheet — strong enough to weather a downturn
80/100 earnings predictability — you can trust these numbers
11.5x trailing p/e — the market's not buying it — or you found a deal
1.9% dividend yield — cash in your pocket every quarter
11.3% return on capital — nothing to write home about
XVARY composite: 72/100 — average
What They Do
Primerica sells term life insurance and investment products through a huge contractor sales force in the U.S. and Canada.
Primerica wins with reach, not glamour. It had 151,611 licensed sales reps and insured 5.5 million lives as of 12/31/24, according to company and data. That contractor model means you get a huge distribution footprint without paying for a giant employee base, with just 2,874 employees supporting the platform.
How They Make Money
$3.3B
annual revenue · their business grew +6.6% last year
Term life insurance
$1.35B
+6.0%
Mutual funds
$0.78B
+7.0%
Annuities
$0.53B
+5.0%
Managed investments
$0.40B
+8.0%
Other financial products
$0.24B
+4.0%
The Products That Matter
Premiums and underwriting
Term Life Insurance
$2.6B · 79% of revenue
it's the core business: $2.6B in revenue, growing 4.2%, and still carrying most of the investment case.
core engine
Asset-based and product fees
Investment & Savings Products
$0.7B · 21% of revenue
this $0.7B segment grew 5.7% last year. it's smaller, but it's the cleanest path to making Primerica look less like a one-product company.
diversification lever
Recruits and serves agents
Distribution Network
130,000 people · $3.3B base
this is the part that turns a $3.3B revenue model into a recurring sales machine, and it touches the whole business.
sales engine
Key Numbers
11.5x
trailing p/e
P/E ratio → how many dollars you pay for each dollar of earnings → so what: you are paying a lower multiple than many steady compounders for a business with 12.0% projected earnings growth.
25%
return on equity
Return on equity → profit generated from shareholder money → so what: Primerica turns every $1 of equity into $0.25 of profit, which is strong for an insurer.
1.9%
dividend yield
Dividend yield → your cash payout from owning the stock → so what: you get paid while you wait, and the projected dividend growth rate is 15.5% versus 12.0% projected earnings growth.
$324
18-month target
Price target → a base-case estimate of where the stock can trade → so what: this points to about 25% upside from $258.58 if execution stays on track.
Financial Health
A
Strength
- balance sheet grade A — very strong financial position
- risk rank 2 — safer than 80% of stocks
- price stability 80 / 100
- long-term debt $1.8B (18% of capital)
- return on equity 25% — $0.25 profit for every $1 investors have put in
A with balance sheet grade and risk rank standing out. your money faces less risk here than at most public companies.
Total Return vs. Market
You invested $10000 in PRI 3 years ago → it's now worth $19280.
The index would have given you $13920.
source: institutional data · total return
What Just Happened
beat estimates
Primerica's latest quarter was strong, with EPS hitting $6.13 versus a $5.64 estimate.
institutional data said the top line increased roughly 8% vs. prior year in the third quarter, while EPS rose 31% to $6.35. The term life operation posted steady growth, which is the quiet part here: the core engine is still working.
$2.4B
revenue
$6.13
eps
8.7%
earnings surprise
the number that mattered
EPS rising to $6.35 in the Q3 snapshot matters most because it shows operating leverage in a business that only grew the top line by about 8%.
-
Primerica reported impressive results for the third quarter.
-
The top line increased roughly 8% year to year.
-
Earnings per share rose 31%, to $6.35.
-
The term life operation posted steady growth.
-
Its licensed sales force rose modestly, and term life revenues increased 3% for the quarter.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. Plain English, no spam.
Weekly updates
Earnings alerts
Plain English
No spam
What Could Go Wrong
The #1 risk is sales force attrition inside Primerica's 130,000-person distribution network.
High
Sales force attrition
Primerica's pitch to investors starts with the 130,000-person rep network. if recruiting or retention weakens, the whole distribution engine slows.
why it matters: that network supports the entire $3.3B revenue base
Med
Term life concentration
Term Life Insurance produces $2.6B of revenue, or 79% of the business. that is focus, but it is also concentration.
why it matters: one segment still carries most of the earnings story
Med
Regulatory and market sensitivity
Primerica sells regulated financial products in the US and Canada, and its Investment & Savings Products segment generates $0.7B of revenue. rule changes or weaker markets pressure the smaller diversification leg first.
why it matters: 21% of revenue comes from investment and savings products
79% of revenue comes from term life insurance, so any crack in agent productivity or policy demand hits the core business fast.
Source: institutional data · regulatory filings · risk analysis
Pay Attention To
Calendar
Q1 2026 earnings
expected 2026-05-06. the headline check is simple: $5.68 EPS estimate versus what they actually print.
Metric
Term life policy growth
management guides for 2–3% policy growth in 2026. if the core segment misses that, the cheap multiple will stay cheap.
Trend
Investment & savings growth
the target is 5–7% growth in 2026. this is the part of the story that can make Primerica look more balanced over time.
Risk
Institutional sponsorship
3q2025 had 219 buyers versus 245 sellers. if that keeps leaning negative, valuation support may stay theoretical.
Analyst Rankings
short-term outlook
average
momentum score 3 — in human-speak, analysts do not see a near-term breakout.
risk profile
above average
stability score 2 means this is safer than roughly 80% of stocks. not risk-free, just steadier.
chart momentum
average
technical score 3 says the chart is behaving normally. nothing euphoric, nothing broken.
earnings predictability
80 / 100
management usually lands near expectations. that lowers surprise risk, but it also means the market rarely gets shocked into paying up.
Source: institutional data
Institutional Activity
219 buyers vs. 245 sellers in 3q2025. total institutional holdings: 30.0M shares.
Source: institutional data
Price Targets
3-5 year target range
$221
$427
$259
Current price
$324
Target midpoint · +25% from current · 3-5yr high: $430 (+65% · 15% ann'l return)
Want the deeper analysis?
The full deep dive: DCF model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
See plans from $5/moThe Deep Dive